Literature DB >> 23031286

Novel insights into the development of chagasic cardiomyopathy: role of PI3Kinase/NO axis.

Danilo Roman-Campos1, Policarpo Sales-Junior, Hugo L Duarte, Enéas R Gomes, Aline Lara, Paula Campos, Nazareth N Rocha, Rodrigo R Resende, Anderson Ferreira, Sílvia Guatimosim, Ricardo T Gazzinelli, Catherine Ropert, Jader S Cruz.   

Abstract

BACKGROUND: Chagas' disease is one of the leading causes of heart failure in Latin American countries. Despite its great social impact, there is no direct evidence in the literature explaining the development of heart failure in Chagas' disease. Therefore, the main objective of the study was to investigate the development of the Chagas' disease towards its chronic phase and correlate with modifications in the cellular electrophysiological characteristics of the infected heart. METHODS AND
RESULTS: Using a murine model of Chagas' disease, we confirmed and extended previous findings of altered electrocardiogram and echocardiogram in this cardiomyopathy. The observed changes in the electrocardiogram were correlated with the prolonged action potential and reduced transient outward potassium current density. Reduced heart function was associated with remodeling of intracellular calcium handling, altered extracellular matrix content, and to a set of proteins involved in the control of cellular contractility in ventricular myocytes. Furthermore, disruption of calcium homeostasis was partially due to activation of the PI3Kinase/nitric oxide signaling pathway. Finally, we propose a causal link between the inflammatory mediators and heart remodeling during chagasic cardiomyopathy.
CONCLUSION: Altogether our results demonstrate that heart failure in Chagas' disease may occur due to electrical and mechanical remodeling of cardiac myocytes, and suggest that AKT/PI3K/NO axis could be an important pharmacological target to improve the disease outcome.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac electrophysiology; Chagas' disease; Heart failure; Hypertrophy; Intracellular calcium; Nitric oxide

Mesh:

Substances:

Year:  2012        PMID: 23031286     DOI: 10.1016/j.ijcard.2012.09.020

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

Review 1.  Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes.

Authors:  Alexandre J S Ribeiro; Olivier Schwab; Mohammad A Mandegar; Yen-Sin Ang; Bruce R Conklin; Deepak Srivastava; Beth L Pruitt
Journal:  Circ Res       Date:  2017-04-11       Impact factor: 17.367

2.  Altered Cardiomyocyte Function and Trypanosoma cruzi Persistence in Chagas Disease.

Authors:  Jader Santos Cruz; Artur Santos-Miranda; Policarpo Ademar Sales-Junior; Renata Monti-Rocha; Paula Peixoto Campos; Fabiana Simão Machado; Danilo Roman-Campos
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

3.  Cardiomyocyte dysfunction during the chronic phase of Chagas disease.

Authors:  Danilo Roman-Campos; Policarpo Sales-Júnior; Hugo Leonardo Duarte; Eneas Ricardo Gomes; Silvia Guatimosim; Catherine Ropert; Ricardo Tostes Gazzinelli; Jader Santos Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-04       Impact factor: 2.743

Review 4.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

5.  Correlation of transforming growth factor-β1 and tumour necrosis factor levels with left ventricular function in Chagas disease.

Authors:  Eduardo Ov Curvo; Roberto R Ferreira; Fabiana S Madeira; Gabriel F Alves; Mayara C Chambela; Veronica G Mendes; Luiz Henrique C Sangenis; Mariana C Waghabi; Roberto M Saraiva
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-19       Impact factor: 2.743

6.  Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.

Authors:  Maria C Silva; Marcela Davoli-Ferreira; Tiago S Medina; Renata Sesti-Costa; Grace K Silva; Carla D Lopes; Lucas E Cardozo; Fábio N Gava; Konstantina Lyroni; Fabrício C Dias; Amanda F Frade; Monique Baron; Helder I Nakaya; Florêncio Figueiredo; José C Alves-Filho; Fernando Q Cunha; Christos Tsatsanis; Christophe Chevillard; Edecio Cunha-Neto; Emilio Hirsch; João S Silva; Thiago M Cunha
Journal:  Nat Commun       Date:  2018-04-17       Impact factor: 14.919

7.  Reactive oxygen species and nitric oxide imbalances lead to in vivo and in vitro arrhythmogenic phenotype in acute phase of experimental Chagas disease.

Authors:  Artur Santos-Miranda; Julliane Vasconcelos Joviano-Santos; Grazielle Alves Ribeiro; Ana Flávia M Botelho; Peter Rocha; Leda Quercia Vieira; Jader Santos Cruz; Danilo Roman-Campos
Journal:  PLoS Pathog       Date:  2020-03-11       Impact factor: 6.823

8.  The Importance of Time-Course Studies Using Experimental Models of Cardiac Diseases.

Authors:  Diego Santos Souza; Danilo Roman-Campos
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

9.  Impact of IFN-γ Deficiency on the Cardiomyocyte Function in the First Stage of Experimental Chagas Disease.

Authors:  Danilo Roman-Campos; Policarpo Sales-Junior; Alexandre D Costa; Diego Santos Souza; Artur Santos-Miranda; Julliane V Joviano-Santos; Catherine Ropert; Jader S Cruz
Journal:  Microorganisms       Date:  2022-01-25

10.  Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy.

Authors:  Thaise Lara Teixeira; Fabrício Castro Machado; Aline Alves da Silva; Samuel Cota Teixeira; Bruna Cristina Borges; Marlus Alves Dos Santos; Flávia Alves Martins; Paula Cristina Brígido; Adele Aud Rodrigues; Ana Flávia Oliveira Notário; Bruno Antônio Ferreira; João Paulo Silva Servato; Simone Ramos Deconte; Daiana Silva Lopes; Veridiana Melo Rodrigues Ávila; Fernanda de Assis Araújo; Tatiana Carla Tomiosso; Marcelo José Barbosa Silva; Claudio Vieira da Silva
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.